Concepedia

Lorenzo Spagnuolo

LS

9

Publications

518

Citations

9

H-Index

2013

Active since

Affiliations

University of Fribourg(Current)

University of Geneva

Oncode Institute

The Netherlands Cancer Institute

San Raffaele University of Rome

Lorenzo Spagnuolo is an author at University of Fribourg specializing in immunotherapy, immunology, and medicine.

ORCID

Top concepts

Publications per year

2013–2023

9

Publications

9

IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

Olga Blomberg, Lorenzo Spagnuolo, Hannah Garner et al. · Cancer Cell · 2022 · 192 citations · Full text

, , +9

TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function

Thibaud Spinetti, Lorenzo Spagnuolo, Inès Mottas et al. · OncoImmunology · 2016 · 79 citations · Full text

, , +17

Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation

Inès Mottas, Ahmet Bekdemir, Alessandra Cereghetti et al. · Biomaterials · 2018 · 58 citations · Full text

, , +11

Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade

Chiara Secondini, Oriana Coquoz, Lorenzo Spagnuolo et al. · OncoImmunology · 2017 · 56 citations · Full text

Neoadjuvant immune checkpoint blockade triggers persistent and systemic T <sub>reg</sub> activation which blunts therapeutic efficacy against metastatic spread of breast tumors

Olga Blomberg, Kevin Kos, Lorenzo Spagnuolo et al. · OncoImmunology · 2023 · 55 citations · Full text

Rows per page

1–5 of 9